Atlas Trials

Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine

Clinical trial NCT01926587 · COMPLETED

Trial details

NCT number
NCT01926587
Sponsor
Traws Pharma, Inc.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Myelodysplastic SyndromeAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia
Start date
2013-08-01
Primary completion
2020-12-08
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.